GLP-1 Receptor Agonists

Table of Contents☰

About GLP-1 Receptor Agonists:

Glucagon-Like Peptide (GLP)-1 receptor agonists mimic a hormone that regulates appetite and blood sugar levels, for managing obesity.
By specifically binding to the key hormone GLP-1, it regulates blood glucose levels and lipid metabolism.
This receptor and its agonists hold significant therapeutic potential, reshaping the treatment approaches for multiple diseases, including diabetes, cardiovascular disorders, and neurodegenerative diseases.
GLP-1 agonists are most often injectable medications, meaning you inject a liquid medication with a needle and syringe.
The new class of GLP-1 receptor agonists, that included drugs such as semaglutide and tirzepatide, “have the potential to be transformative.
- In medication terms, an agonist is a manufactured substance that attaches to a cell receptor and causes the same action as the naturally occurring substance.

What is GLP-1?

GLP-1 is a key hormone that plays an integral role in regulating blood glucose levels, lipid metabolism, and several other crucial biological functions.
It is released by the intestines in response to food intake.

Q1: What is Diabetes?

It is a chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces.

News: WHO scientists endorse weight loss drugs for controlling obesity: What does it mean for therapies?